Graves’ thyrotoxicosis as a manifestation Of immune reconstitution inflammatory syndrome in HIV patients on antiretroviral therapy

Background: A 47-year-old lady with HIVV infection presented with progressive weight loss, heat intolerance and tremor 46 months after initiation of antiretroviral therapy (ART). No previous thyroid disorders or significant family history. She has bilateral exophthalmos and diffuse neck swelling. La...

Full description

Bibliographic Details
Main Authors:	Goh, Kian Guan, Zakaria, Miza Hiryanti, Shahar, Mohammad Arif, Omar, Ahmad Marzuki
Format:	Conference or Workshop Item
Language:	English English
Published:	2017
Subjects:	R Medicine (General) RC Internal medicine
Online Access:	http://irep.iium.edu.my/58565/ http://irep.iium.edu.my/58565/3/GIRIS%20poster%20ver%201.0.pdf http://irep.iium.edu.my/58565/4/Graves%20disease%20HIV%20immune%20reconstitution.pdf

id	iium-58565
recordtype	eprints
spelling	iium-585652017-11-20T03:18:57Z http://irep.iium.edu.my/58565/ Graves’ thyrotoxicosis as a manifestation Of immune reconstitution inflammatory syndrome in HIV patients on antiretroviral therapy Goh, Kian Guan Zakaria, Miza Hiryanti Shahar, Mohammad Arif Omar, Ahmad Marzuki R Medicine (General) RC Internal medicine Background: A 47-year-old lady with HIVV infection presented with progressive weight loss, heat intolerance and tremor 46 months after initiation of antiretroviral therapy (ART). No previous thyroid disorders or significant family history. She has bilateral exophthalmos and diffuse neck swelling. Laboratory findings showed high level of thyroxine and suppressed thyroid-stimulating hormone (TSH). Anti-thyroglobulin (Anti-TG) and anti-thyroperoxidase (Anti-TPO) level were levated (4619.933 IU/mL and 359.745 IU/mL respectively). HIV viral loas was not detected since 32 months post ART. Her CD4 count maintained between 280-400. Treatment: She was started on oral carbimazole 30mg daily and subsequently tapered down. The symptoms of thyrotoxicosis were controlled after initiation of antithyroid. Her ART regime initially was stavudine/lamivudine/nevirapine; changed to zidovudine/lamivudine/efavirenz after trend of CD4 counts showing reduction. The regime was switched to zidovudine/lamivudine/nevirapine after the diagnosis of Graves’ IRIS. Discussion: Graves disease is a recognized manifestation of organ-specific immune reconstitution inflammatory syndrome. This is postulated as re-expansion of naïve CD4 cells after suppression of the HIV virus. Mean time until development of Graves’ disease is between 8-53 months post-treatment. In this case, she developed thyrotoxicosis symptoms at 46 months. In a large single centre cohort study, non-nucleoside reverse transcriptase, particularly efavirenz, is associated with hyperthyroidism and protease inhibitors is related to hypothyroidism. However, our patient received short duration (2 months) of efavirenz before changing to other ART. The recovery of CD4 counts coupled with detection of antithyroid antibodies makes it more likely to be Graves’ IRIS. Conclusion: Graves’ IRIS is a rare manifestation of thyrotoxicosis among ART-treated HIV patients. It must be suspected if patinets exhibit thyrotoxicosis symptoms. Further studies are required to determine the effect of ART in development of autoimmunity in the thyroid gland. 2017-05 Conference or Workshop Item NonPeerReviewed application/pdf en http://irep.iium.edu.my/58565/3/GIRIS%20poster%20ver%201.0.pdf application/pdf en http://irep.iium.edu.my/58565/4/Graves%20disease%20HIV%20immune%20reconstitution.pdf Goh, Kian Guan and Zakaria, Miza Hiryanti and Shahar, Mohammad Arif and Omar, Ahmad Marzuki (2017) Graves’ thyrotoxicosis as a manifestation Of immune reconstitution inflammatory syndrome in HIV patients on antiretroviral therapy. In: MEMS Annual Congress 2017, 19-21 May 2017, Kuala Lumpur. (Unpublished)
repository_type	Digital Repository
institution_category	Local University
institution	International Islamic University Malaysia
building	IIUM Repository
collection	Online Access
language	English English
topic	R Medicine (General) RC Internal medicine
spellingShingle	R Medicine (General) RC Internal medicine Goh, Kian Guan Zakaria, Miza Hiryanti Shahar, Mohammad Arif Omar, Ahmad Marzuki Graves’ thyrotoxicosis as a manifestation Of immune reconstitution inflammatory syndrome in HIV patients on antiretroviral therapy
description	Background: A 47-year-old lady with HIVV infection presented with progressive weight loss, heat intolerance and tremor 46 months after initiation of antiretroviral therapy (ART). No previous thyroid disorders or significant family history. She has bilateral exophthalmos and diffuse neck swelling. Laboratory findings showed high level of thyroxine and suppressed thyroid-stimulating hormone (TSH). Anti-thyroglobulin (Anti-TG) and anti-thyroperoxidase (Anti-TPO) level were levated (4619.933 IU/mL and 359.745 IU/mL respectively). HIV viral loas was not detected since 32 months post ART. Her CD4 count maintained between 280-400. Treatment: She was started on oral carbimazole 30mg daily and subsequently tapered down. The symptoms of thyrotoxicosis were controlled after initiation of antithyroid. Her ART regime initially was stavudine/lamivudine/nevirapine; changed to zidovudine/lamivudine/efavirenz after trend of CD4 counts showing reduction. The regime was switched to zidovudine/lamivudine/nevirapine after the diagnosis of Graves’ IRIS. Discussion: Graves disease is a recognized manifestation of organ-specific immune reconstitution inflammatory syndrome. This is postulated as re-expansion of naïve CD4 cells after suppression of the HIV virus. Mean time until development of Graves’ disease is between 8-53 months post-treatment. In this case, she developed thyrotoxicosis symptoms at 46 months. In a large single centre cohort study, non-nucleoside reverse transcriptase, particularly efavirenz, is associated with hyperthyroidism and protease inhibitors is related to hypothyroidism. However, our patient received short duration (2 months) of efavirenz before changing to other ART. The recovery of CD4 counts coupled with detection of antithyroid antibodies makes it more likely to be Graves’ IRIS. Conclusion: Graves’ IRIS is a rare manifestation of thyrotoxicosis among ART-treated HIV patients. It must be suspected if patinets exhibit thyrotoxicosis symptoms. Further studies are required to determine the effect of ART in development of autoimmunity in the thyroid gland.
format	Conference or Workshop Item
author	Goh, Kian Guan Zakaria, Miza Hiryanti Shahar, Mohammad Arif Omar, Ahmad Marzuki
author_facet	Goh, Kian Guan Zakaria, Miza Hiryanti Shahar, Mohammad Arif Omar, Ahmad Marzuki
author_sort	Goh, Kian Guan
title	Graves’ thyrotoxicosis as a manifestation Of immune reconstitution inflammatory syndrome in HIV patients on antiretroviral therapy
title_short	Graves’ thyrotoxicosis as a manifestation Of immune reconstitution inflammatory syndrome in HIV patients on antiretroviral therapy
title_full	Graves’ thyrotoxicosis as a manifestation Of immune reconstitution inflammatory syndrome in HIV patients on antiretroviral therapy
title_fullStr	Graves’ thyrotoxicosis as a manifestation Of immune reconstitution inflammatory syndrome in HIV patients on antiretroviral therapy
title_full_unstemmed	Graves’ thyrotoxicosis as a manifestation Of immune reconstitution inflammatory syndrome in HIV patients on antiretroviral therapy
title_sort	graves’ thyrotoxicosis as a manifestation of immune reconstitution inflammatory syndrome in hiv patients on antiretroviral therapy
publishDate	2017
url	http://irep.iium.edu.my/58565/ http://irep.iium.edu.my/58565/3/GIRIS%20poster%20ver%201.0.pdf http://irep.iium.edu.my/58565/4/Graves%20disease%20HIV%20immune%20reconstitution.pdf
first_indexed	2023-09-18T21:22:50Z
last_indexed	2023-09-18T21:22:50Z
_version_	1777411996284616704

Graves’ thyrotoxicosis as a manifestation Of immune reconstitution inflammatory syndrome in HIV patients on antiretroviral therapy

Similar Items